pharmaceutical investing Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse
pharmaceutical investing Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2017 Financial Results
pharmaceutical investing Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse
Locksley Announces Major Advancement at Mojave as Structural Mapping Expands Scale of Antimony Target with a 400% Increase in Target Strike Length
